Intelligence Β· Patent portfolio
Regeneron Ireland Designated Patents
Full USPTO pharma patent portfolio for Regeneron Ireland Designated β grant dates, expiration, and drug cross-links.
- Patents
- 8,292
- Expiring β€24m
- 426
Quick answer
Regeneron Ireland Designated has 8,292 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 426 expire within 24 months β use filters for patent-cliff planning.
-
US 6447993
Multi-subtype FIV vaccines
expired -
US 6448072
Transcription factors related to TFIIA
expired -
US 6448045
Inducing insulin gene expression in pancreas cells expressing recombinant PDX-1
expired -
US 6448076
Method for chemically acellularizing a biological tissue sample
expired -
US 6448472
Genetic and epigenetic manipulation of ABC transporters and ectophosphatases for the conference of hormone and herbicide resistance
expired -
US 6444645
Crosslink-stabilized indolicidin analogs
expired -
US 6444192
Diagnostic imaging of lymph structures
expired -
US 6444650
Antisense compositions for detecting and inhibiting telomerase reverse transcriptase
expired -
US 6444872
Large animal model of invasive pulmonary aspergillosis in an immunocompromised host
expired -
US 6444447
Polymer grafting by polysaccharide synthases
expired -
US 6444695
Inhibition of thrombin-induced platelet aggregation by creatine kinase inhibitors
expired -
US 6444446
Calcium binding proteolipid compositions and methods
expired -
US 6439236
Methods for inducing atrial and ventricular rhythms using ultrasound and microbubbles
expired -
US 6440947
Method for treating occlusive peripheral vascular disease and coronary disease
expired -
US 6440672
Compositions and methods for the inhibition of MUC-5 mucin gene expression
expired -
US 6440452
Therapeutic enclosures
expired -
US 6436700
Anti-sense p21 k-ras
expired -
US 6436629
Modulating angiogenesis
expired -
US 6436667
Human NKX-6.1 polypeptide-encoding nucleotide sequences
expired -
US 6437116
VMP-like sequences of pathogenic borrelia
expired -
US 6437128
Cribrostatins 3-5
expired -
US 6433137
TUP1 sequences from Candida albicans and methods for screening agents for inhibiting virulence in Candida albicans using TUP1
expired -
US 6433150
Anthracycline analogues bearing latent alkylating substituents
expired -
US 6433136
Cell density signal protein suitable for treatment of connective tissue injuries and defects
expired -
US 6432918
Methods and compositions for optimization of oxygen transport by cell-free systems
expired -
US 6433147
Death domain containing receptor-4
expired -
US 6428985
Immunosuppressive structural definition of IL-10
expired -
US 6429208
Methods and compositions for restoring impaired cellular immune function
expired -
US 6426086
pH-sensitive, serum-stable liposomes
expired -
US 6426336
Method for treating allergic lung disease
expired -
US 6426058
Enhancement of NMR and MRI in the presence of hyperpolarized noble gases
expired -
US 6426187
Detection of conversion to mucoidy in Pseudomonas aeruginosa infecting cystic fibrosis patients
expired -
US 6426368
Method for preventing and treating alcoholism
expired -
US 6423493
Combinatorial selection of oligonucleotide aptamers
expired -
US 6420428
Treatment and prevention of hepatic disorders
expired -
US 6419897
Use of long-wavelength electromagnetic radiation and photoprotective tumor localizing agents for diagnosis
expired -
US 6417244
Metal oxide compositions and methods
expired -
US 6416759
Antiproliferative Sgk reagents and methods
expired -
US 6417384
Radioiodinated phospholipid ether analogs and methods of using the same
expired -
US 6416758
Antibody conjugate kits for selectively inhibiting VEGF
expired -
US 6414115
Parasitic nematode transglutaminase proteins and uses thereof
expired -
US 6413938
Benzimidazole derivatives for the treatment of viral infections
expired -
US 6413944
Triciribine and analogs as antiviral drugs
expired -
US 6413773
Phosphatidylinositol 3-kinase inhibitors as stimulators of endocrine differentiation
expired -
US 6409990
Macromolecular carrier for drug and diagnostic agent delivery
expired -
US 6410029
2-methoxyestradiol-induced apoptosis in cancer cells
expired -
US 6410049
Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
expired -
US 6410010
Recombinant P53 adenovirus compositions
expired
Frequently asked questions
How many patents does Regeneron Ireland Designated have?
8,292 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Regeneron Ireland Designated patents expire?
426 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.
Where does this data come from?
USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.
Data attribution: Data sources Β· Patent directory